Alfutaimani Alanood S, Alharbi Nouf K, S Alahmari Amirah, A Alqabbani Almaha, Aldayel Abdulaziz M
Nanomedicine Department, King Abdullah International Medical Research Center, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia.
Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University (PNU), P.O Box 84428, Riyadh 11671, Saudi Arabia.
Int J Pharm X. 2024 Nov 18;8:100305. doi: 10.1016/j.ijpx.2024.100305. eCollection 2024 Dec.
Lipid nanoparticles (LNPs) have emerged as promising carriers for delivering therapeutic agents, including mRNA-based immunotherapies, in various biomedical applications. The use of LNPs allows for efficient delivery of drugs, resulting in enhanced targeted delivery to specific tissues or cells. These LNPs can be categorized into several types, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and lipid-polymer hybrid nanoparticles. The preparation of LNPs involves the manipulation of their structural, dimensional, compositional, and physical characteristics via the use of different methods in the industry. Lipids used to construct LNPs can also be derived from various biological sources, such as natural lipids extracted from plants, animals, or microorganisms. This review dives into the different types of LNPs and their preparation methods. More importantly, it discusses all possible biological sources that are known to supply lipids for the creation of LNPs. Natural lipid reservoirs have surfaced as promising sources for generating LNPs. The use of LNPs in drug delivery is expected to increase significantly in the coming years. Herein, we suggest some environmentally friendly and biocompatible sources that can produce lipids for future LNPs production.
脂质纳米颗粒(LNPs)已成为在各种生物医学应用中递送治疗剂(包括基于mRNA的免疫疗法)的有前景的载体。LNPs的使用能够实现药物的高效递送,从而增强对特定组织或细胞的靶向递送。这些LNPs可分为几种类型,包括脂质体、固体脂质纳米颗粒、纳米结构脂质载体和脂质-聚合物杂化纳米颗粒。LNPs的制备涉及通过行业中不同的方法来操控其结构、尺寸、组成和物理特性。用于构建LNPs的脂质也可源自各种生物来源,例如从植物、动物或微生物中提取的天然脂质。本综述深入探讨了不同类型的LNPs及其制备方法。更重要的是,它讨论了所有已知的可为LNPs的制备提供脂质的可能生物来源。天然脂质库已成为生成LNPs的有前景的来源。预计未来几年LNPs在药物递送中的应用将显著增加。在此,我们提出一些可为未来LNPs生产提供脂质的环境友好且生物相容的来源。